Liver cancer is the sixth leading cause of cancer death in the U.S. The most common type of liver cancer in adults is hepatocellular carcinoma, and men are more likely to develop HCC than women. It typically develops in people with long-lasting liver disease caused by hepatitis virus infection or cirrhosis. In many cases, liver cancer is a preventable cancer, so raising awareness about prevention is important.
When Fadyia Lowe went for her annual mammogram this past March, she wasn’t expecting anything unusual. At 42, it was only her third screening. But that routine appointment led to a discovery that would change her perspective forever and potentially save her life. After her early stage breast cancer diagnosis, Lowe, who serves as associate director of prevention in the Violence Intervention and Prevention (VIP) Center at the University of Kentucky, underwent a double mastectomy with reconstruction at UK Markey Cancer Center.
Kentucky Lt. Gov. Jacqueline Coleman visited UK HealthCare’s Albert B. Chandler Hospital on Friday to recognize the importance of cancer education and prevention in the Commonwealth and highlight two innovative UK Markey Cancer Center programs that are training the next generation of cancer researchers and health care providers.
The ARCADIA study was a multicenter, double-blind, randomized clinical trial conducted between 2017 and 2020.
A new study has found a surprising link between high levels of methylmalonic acid and the weakening of CD8+ T cells, shedding light on potential pathways through which aging may promote lung cancer progression. Moffitt Cancer Center researchers have found new insights into how metabolic changes associated with aging can impact immune responses against tumors.
October is Breast Cancer Awareness Month, and fittingly, University of New Mexico Comprehensive Cancer Center biologist Curt Hines, PhD, has published a pair of papers that comprehensively describe the twelve major types of cells in the human breast.
The University of New Mexico Comprehensive Cancer Center has successfully received reaccreditation from the Commission on Cancer (CoC), a quality program of the American College of Surgeons. The ACS CoC is a consortium of professional organizations dedicated to improving survival and quality of life for patients with cancer by setting and raising standards.
Smokers who are diagnosed with cancer now have more incentive to quit, as researchers from The University of Texas MD Anderson Cancer Center have found survival outcomes were optimized when patients quit smoking within six months of their diagnosis.
NEW YORK, October 31, 2024 – Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments:
The AbbVie Foundation, a nonprofit working to advance health equity, is donating $75 million to UChicago Medicine to support the $815 million cost to construct a state-of-the-art cancer care pavilion, the first and only freestanding facility of its kind in Illinois.
Lifesaving cancer therapies can cause serious side effects, both immediately and later in life. "It is essential to continue to study innovative approaches that will eradicate the disease but won't diminish the quality of life for patients diagnosed with cancer," says Roberto Leon-Ferre, M.D., a breast medical oncologist at Mayo Clinic. With breast cancer rates rising among younger people, the need for treatments that provide excellent outcomes with fewer side effects is only increasing.
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
A new analysis led by researchers at Washington University School of Medicine in St. Louis has revealed detailed 3D maps of the internal structures of multiple tumor types. These cancer atlases reveal how different tumor cells — and the cells of a tumor’s surrounding environment — are organized, in 3D, and how that organization changes when a tumor spreads to other organs. The detailed findings offer scientists valuable blueprints of tumors that could lead to new approaches to therapy and spark a new era in the field of cancer biology, according to the researchers.
Dr. Sedrak, who directs the Cancer and Aging Program at the UCLA Health Jonsson Comprehensive Cancer Center(Link opens in new window), discusses what inspired his work, the challenges cancer survivors face as they age, and the exciting advancements in cancer and aging research that could reshape patient care in the years to come.
Researchers at the Icahn School of Medicine at Mount Sinai have discovered a way that ovarian cancer tumors manipulate their environment to resist immunotherapy and identified a drug target that could overcome that resistance. The study, published in the October 30 online issue of Cell used a cutting-edge spatial genomics technology and preclinical animal models, with tumor specimens from ovarian cancer patients further validating the findings. They found that ovarian cancer cells produce a molecule called Interleukin-4 (IL-4), which is typically associated with asthma and the skin condition eczema, also known as atopic dermatitis. The study went on to find that the cancer cells used IL-4 to create a protective environment that kept away killer immune cells, making the tumors resistant to immunotherapy. A drug, dupilumab, which blocks IL-4’s activity, has been approved by the Food and Drug Administration (FDA) and is already used to treat asthma and eczema. This new study suggests dupi
A new, large study led by American Cancer Society (ACS) researchers found that lack of health insurance coverage accounts for a significant proportion of racial and ethnic disparities in advanced-stage diagnosis of multiple cancers.
Nitin Yerram, MD, co-director of urologic oncology at JTCC, received a grant from Artera to assess the MMAI platform for estimating prostate cancer aggressiveness in men who have had a prostate biopsy and underwent surgery.
An international team of imaging, engineering and cancer experts is developing a novel mobile breast cancer diagnostic kit to improve early diagnosis in low- and middle-income countries — such as Uganda, where systemic delays lead to an advanced stage diagnosis in 70% of breast cancer cases.
The Roswell Park team has developed a new method to measure mutation loads across species, revealing the role of the "dark genome" — ancient, virus-like genes that affect cellular function. The findings support further exploration of antiviral drugs as potential tools to target the dark genome in controlling cancer.
Showing results
1–1 of 1
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
